ArtJen’s Impressive Weapon In The War On Obesity Now Available In Southern Ontario’s Health Smart Drug Stores
ArtJen is pleased to announce that its new weight loss product FBCx is now available in all Windsor and area Health Smart Drug Stores. This marks the first time that ArtJen’s dietary weight loss supplement has been made available in Canadian pharmacies.
(PRWEB) February 9, 2006
ArtJen Complexus Holdings Corp. is pleased to announce that its new weight loss product FBCx is now available in all Windsor and area Health Smart Drug Stores. This marks the first time that ArtJen’s dietary weight loss supplement has been available in Canadian drug stores. In an effort to differentiate FBCx from products that make similar claims ArtJen has avoided placing FBCx in pharmacies. This change on ArtJen’s part was made possible by Health Smart’s agreement to place FBCx on the pharmacy counter.
George Grunberger, M. D., K-L Catherine Jen, Ph. D. and Joseph Artiss, Ph. D. recently presented the findings of their double blind placebo controlled clinical trial on obese volunteers with type 2 diabetes at both the June meeting of the American Diabetes Association and the October meeting of the North American Association for the Study of Obesity. Important conclusions to the Clinical Study include:
FBCx is effective in reducing and/or maintaining body weight in patients with type 2 diabetes.
FBCx is effective in reducing elevated blood lipid levels.
FBCx can be easily incorporated into a diabetes management regimen.
FBCx was shown to bind more than 9 times its own weight in dietary fat in human volunteers.
Dr Grunberger, of the renowned Grunberger Diabetes Institute states that: “About 90 % of his patients with type 2 diabetes are obese and that obesity is the number 2 preventable cause of death in the U. S.” Before FBCx, “There was no known effective way to keep weight off.” Said Dr Grunberger “This discovery, which can help shed pounds or prevent weight gain, is a real progress.” Dr Jen said “Unlike claims made by others, this product actually works.”
The important results of this clinical trial could change the dietary management of patients with type 2 diabetes. Subjects in preclinical trials, including non diabetic patients showed dramatic and consistent weight loss. Many reported significant weight loss in the first few weeks and over 40 pounds of weight loss have been recorded. Employing a natural fiber each 1 gram tablet binds more than 9 grams of dietary fat effectively preventing the fat from being absorbed by the body. Dr. Artiss said: “There’s too much information to go into detail here, however, there is more scientific information available at our educational website: www. artjen. net. Artiss also notes that the original animal study that he and Dr. Jen conducted can be found in the February issue of the scientific journal Metabolism Clinical and Experimental.
By taking the recommended 2 tablets per typical North American meal results in a safe weight loss of 1 to 1.5 pounds per week. The product is now available under the FBCx name, Fat Binding Complexer. A US patent has been awarded to the ArtJen Company for FBCx, worldwide patents are pending.
A complete list of retailers may be found at www. artjen. net by clicking on “Shop In Person”. Purchases may also be made online at www. artjen. net or by calling toll free 1-877-4-ARTJEN.
For further information contact Dr. Joe Artiss at 1-877-4-ARTJEN.
###
